We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

49 hedge funds and large institutions have $33.2M invested in AVEO Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $9K | Put options by funds: $3K

180% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 5

107% more capital invested

Capital invested by funds: $16M → $33.2M (+$17.2M)

100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 6

11% more funds holding

Funds holding: 44 → 49 (+5)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
49
Holders Change
+5
Holders Change %
+11.36%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
14
Increased
12
Reduced
6
Closed
5
Calls
$9K
Puts
$3K
Net Calls
+$6K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$4.33M
2
AC
Armistice Capital
New York
+$3.47M
3
ACA
Avoro Capital Advisors
New York
+$2.84M
4
SFM
Sphera Funds Management
Israel
+$2.09M
5
6CM
683 Capital Management
New York
+$1.65M

Top Sellers

Rank Fund Capital Flow
1
SCM
Sarissa Capital Management
Connecticut
-$496K
2
CAM
Cormorant Asset Management
Massachusetts
-$280K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$158K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$127K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$42K -$158K -21,813 -75%
VKH
27
Virtu KCG Holdings
New York
$27K +$23.6K +3,268 +241%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$20K – – –
Millennium Management
29
Millennium Management
New York
$18K +$22.6K +3,123 New
State Street
30
State Street
Massachusetts
$15K – – –
GC
31
Guggenheim Capital
Illinois
$12K +$1.48K +205 +11%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$11K – – –
LPL Financial
33
LPL Financial
California
$9K +$10.1K +1,400 New
EWM
34
Edge Wealth Management
New York
$6K – – –
ECM
35
Elgethun Capital Management
South Dakota
$6K – – –
Citadel Advisors
36
Citadel Advisors
Florida
$6K +$7.93K +1,098 New
Bank of America
37
Bank of America
North Carolina
$3K -$72 -10 -2%
CAG
38
Crestwood Advisors Group
Massachusetts
$3K +$3.65K +506 New
Creative Planning
39
Creative Planning
Kansas
$2K – – –
CG
40
Cutler Group
California
$1K – – –
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
UBS Group
42
UBS Group
Switzerland
$1K +$715 +99 +430%
CFA
43
CT Financial Advisors
Pennsylvania
$472 – – –
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
– -$127K -23,470 Closed
SIM
45
Spark Investment Management
New York
– -$51K -9,580 Closed
TSS
46
Two Sigma Securities
New York
– -$8K -1,474 Closed
TRCT
47
Tower Research Capital (TRC)
New York
– -$1K -108 Closed
Simplex Trading
48
Simplex Trading
Illinois
– +$549 +76 New
DADC
49
D.A. Davidson & Co
Montana
– +$722 +100 New
1
2

AVEO Hedge Fund Activity: Q1 2017 in Review

49 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2017, worth a combined $33.2M — up 107% from $16M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new AVEO positions and 5 closed out — a net gain of 9 holders — while 12 added to existing stakes and 6 trimmed.

The largest buyer was NEA Management Company, adding an estimated $4.33M. The largest seller was Sarissa Capital Management, cutting an estimated $496K.

  • 49 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2017, up from 44 in Q4 2016.
  • Funds reported $33.2M of AVEO Pharmaceuticals, Inc. stock for Q1 2017, up 107% quarter-over-quarter.
  • 14 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2017 and 5 closed out, a net change of +9 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2017 was NEA Management Company, an estimated $4.33M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q1 2017 was Sarissa Capital Management, an estimated $496K sold.

Based on aggregated 13F filings for Q1 2017.